Strategy
Reorganising for the Future
Succeeding in the new pharmaceutical industry
The old pharmaceutical industry is dead the one that was a fully integrated behemoth with a RD and commercial operation regularly launching blockbuster drugs for diseases that affects millions of people The era of the mad men in marketing and sales strategizing with ad agencies on positioning brand
Indian Pharma
The Discovery Metamorphosis
With NCEs in the pipeline the Indian pharma has adopted the innovation path with enthusiastic diligence More than a dozen Indian companies are now focussing on novel drug discovery and taking different routes viz partnering with international pharma companies outlicensing researching collaboratively with government and academic institutions etc Th...
Regulation of Nanomedicines
Possible challenges
Nanomedicines refer to drugs medical devices and health products developed using nanotechnology with the aim of diagnosing monitoring and treating diseases at the molecular level Nanomedicines can be used to achieve the same therapeutic effect at smaller doses than their conventional counterparts due to t
Whither Pharma
Possible challenges
To predict the future of pharma we need a powerful tool and fortunately in evolutionary theory we have what philosopher Daniel Dennett called the best idea ever First used to understand the complexity of life evolution is now used by management scientists to explain and predict many other complex adaptive systems including whole industries Evolutio...
Risk Management of Contamination
Prevention or cure?
These are very interesting exciting and challenging times in the world of pharmaceutical products companies and regulatory bodies There is a very valid argument that the pharmaceutical industry has some vital decisions to make regarding its future particularly with about outsourcing production and the introduction of new technologies Recent trends...
Partnerships and Innovation
The growth factors
How important will be strategic alliances and partnerships for the growth of Indian pharmaceutical market Alliances and partnerships will be very important because of two reasons The Indian market has already entered into the patent era and Indian companies still have very lean product pipeline as of now Developing a product pipeline is being...
First Compulsory License
Likely to impact the pharmaceutical industry in India
The grant of compulsory license CL to Natco Pharma in relation to Bayer Corporation Bayers patented anticancer drug Sorafenib Tosyalte sold under trademark NEXAVAR Drug is expected to have a major impact on the strategies devised by both generic and innovative companies Since this is the first time that the CL has been granted in India several issu...
US Biotech and Indian Pharma
Is there a win-win partnering strategy?
Recent trends in the global pharmaceutical industry suggest that the time may be right for a new business model to emerge Especially a model that draws upon the existing strengths of US biotechnology companies and Indian pharmaceutical companies to costeffectively discover and develop new drugs This would help simultaneously address the considerabl...
New FIPNET Paradigm
Powered by technology and innovation
As a critical effort that has been ongoing for the last several years the pharmaceutical industry continues to pursue transformational change in anticipation or in the shadow of lost blockbuster drug revenue due to patent expirations At the same time it is becoming increasingly difficult more complex and costly to bring new drugs to market The rati...
Achieving Greater Efficiency in the Production of Biosimilar Antibodies
Biosimilars and biobetters represent a new and exciting market for therapeutic manufacturers Recent reports indicate that the market for biosimilar monoclonal antibodies MAb will reach more than US billion in with the majority of revenues coming from established markets for MAbsnamely the USA France Germany Italy Spain the UK and Japan Additional...
